ResearcherChanghai HospitalNo recent work listed

Jingzhu Cao

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5108814583. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2022: 1 paper

Papers 1

UBE2C promotes the progression of pancreatic cancer and glycolytic activity via EGFR stabilization-mediated PI3K-Akt pathway activation. Co-author DOI 10.21037/jgo-22-516 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Chenming Ni · 1 shared paper, 2022 · strength 0.16
- Paper UBE2C promotes the progression of pancreatic cancer and glycolytic activity via EGFR stabilization-mediated PI3K-Akt pa… DOI 10.21037/jgo-22-516 ↗
Liu Ouyang · 1 shared paper, 2022 · strength 0.16
- Paper UBE2C promotes the progression of pancreatic cancer and glycolytic activity via EGFR stabilization-mediated PI3K-Akt pa… DOI 10.21037/jgo-22-516 ↗
Hao Hu · 1 shared paper, 2022 · strength 0.16
- Paper UBE2C promotes the progression of pancreatic cancer and glycolytic activity via EGFR stabilization-mediated PI3K-Akt pa… DOI 10.21037/jgo-22-516 ↗
Gang Nie · 1 shared paper, 2022 · strength 0.16
- Paper UBE2C promotes the progression of pancreatic cancer and glycolytic activity via EGFR stabilization-mediated PI3K-Akt pa… DOI 10.21037/jgo-22-516 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.